Indianapolis-Gowan Co. LLC, Yuma, Ariz., has reached an agreement with Dow AgroSciences LLC to acquire the rights to its global zoxamide fungicide business, marketed primarily under the brand names Zoxium?äó, Gavel?äó, Electis?äó, Unikat?äó, and Harpon?äó. Zoxamide is used to control oomycete fungi infecting potatoes, vines, and vegetables. Gowan and its subsidiaries will start selling zoxamide and its formulations effective Aug. 1, 2008. Financial terms of the agreement were not disclosed. “The addition of zoxamide expands Gowan’s fungicide portfolio globally, and is consistent with our goal to identify important products that growers need,” said Matt Comer, global marketing manager for Gowan. “Due to the press of competing priorities for new product development, Dow AgroSciences, as a research-based company, has not been able to devote the time and resources needed to position zoxamide for optimal growth,” said David Hindes, global business leader, fungicides. “We believe that zoxamide will be better positioned with Gowan, where it represents a better strategic fit with the company’s portfolio and general business direction.”
Transparency Across the Fertilizer Value-Chain